Related Experiment Videos
Cell cycle regulators and their abnormalities in breast cancer
P L Fernández1, P Jares, M J Rey
1Department of Anatomical Pathology, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Spain. fernandez@medicina:ub.es
Molecular Pathology : MP
|April 8, 1999
Summary
Cancer cells exhibit deregulated proliferation due to cell cycle abnormalities. Key regulators like the retinoblastoma gene and cyclin-dependent kinase inhibitors are frequently altered in breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Cancer cells are characterized by uncontrolled proliferation.
- Aberrant cell cycle regulation is a hallmark of many cancers, including breast cancer.
- Alterations in cell cycle modulators are common in tumor development.
Purpose of the Study:
- To review the role of cell cycle deregulation in breast cancer.
- To highlight common abnormalities in cell cycle regulators in breast tumors.
- To discuss the complex interplay between these regulators.
Main Methods:
- Literature review of cell cycle regulation in cancer.
- Analysis of genetic and protein alterations in breast cancer.
- Examination of regulatory networks controlling cell division.
Main Results:
- Increased and deregulated proliferative activity is a key cancer cell property.
- Defects in retinoblastoma gene and cyclin-dependent kinase inhibitors (e.g., p16, p21, p27) are frequent in breast carcinomas.
- Upregulation of cyclins is also observed in breast tumors.
Conclusions:
- Abnormalities in cell cycle modulators are prevalent in breast cancer.
- These alterations contribute to the uncontrolled proliferation of cancer cells.
- Interactions between these abnormalities suggest a complex regulatory network governing the cell cycle in cancer.